Skip to content
The Policy VaultThe Policy Vault

EntrestoCigna

treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged ≥ 1 year

Preferred products

  • generic sacubitril-valsartan tablets

Initial criteria

  • Patient has tried one Step 1 Product (generic sacubitril-valsartan tablets)

Approval duration

1 year